Medical Information
Canada
 

In order to provide you with relevant and meaningful content we need to know more about you.

Please choose the category that best describes you.

This content is intended for Canadian Healthcare Professionals. Would you like to proceed?

If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.

Our scientific content is evidence-based, scientifically balanced and non-promotional. It undergoes rigorous internal medical review and is updated regularly to reflect new information.

Comirnaty Original & Omicron BA.4/BA.5 COVID-19 mRNA vaccine, Bivalent (Original and Omicron BA.4/BA.5) is indicated as a booster dose for active immunization against COVID-19 caused by SARS-CoV-2 in individuals 5 years of age and older.

The safety and effectiveness of a booster dose of Comirnaty Original & Omicron BA.4/BA.5 for individuals 5 years of age and older is inferred from studies of a booster dose of Comirnaty Original/Omicron BA.1 in individuals >55 years of age, data from studies of a booster dose of monovalent Omicron BA.1 in individuals 18 to ≤55 years of age as well as data from studies which evaluated the primary series and booster vaccination with COMIRNATY.

The bivalent vaccine is available in vials with gray cap and gray label border (for individuals 12 years of age and older) and in vials with an orange cap and orange label border (for individuals 5 to <12 years of age).

Please review the label carefully to ensure that you select the appropriate vaccine for immunization. Please review the Comirnaty or the Comirnaty Original & Omicron BA.4/BA.5, Bivalent Product Monograph for more complete information. Each Product Monograph is available below, at www.pfizer.ca/products, or www.cvdvaccine.ca.

Comirnaty (COVID-19 Vaccine, mRNA) and Comirnaty Original & Omicron BA.4/BA.5 [bivalent]

If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.

Our scientific content is evidence-based, scientifically balanced and non-promotional. It undergoes rigorous internal medical review and is updated regularly to reflect new information.

Comirnaty and Comirnaty Original & Omicron BA.4/BA.5 Quick Finder

Download Product Monograph Note: the information below includes the Part I: Health Professional Information.
Download Product Monograph
Did you find an answer to your question? Yes No
Didn’t find what you were looking for? Contact us.
Report Adverse Event